Your browser doesn't support javascript.
loading
A third dose of the BNT162b2 mRNA vaccine sufficiently improves the neutralizing activity against SARS-CoV-2 variants in liver transplant recipients.
Tomiyama, Takahiro; Suzuki, Rigel; Harada, Noboru; Tamura, Tomokazu; Toshida, Katsuya; Kosai-Fujimoto, Yukiko-; Tomino, Takahiro; Yoshiya, Shohei; Nagao, Yoshihiro; Takeishi, Kazuki; Itoh, Shinji; Kobayashi, Nobuhiro; Ito, Hayato; Yoshio, Sachiyo; Kanto, Tatsuya; Yoshizumi, Tomoharu; Fukuhara, Takasuke.
Afiliación
  • Tomiyama T; Department of Surgery and Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Suzuki R; Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
  • Harada N; Department of Surgery and Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Tamura T; Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
  • Toshida K; Department of Surgery and Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Kosai-Fujimoto Y; Department of Surgery and Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Tomino T; Department of Surgery and Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Yoshiya S; Department of Surgery and Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Nagao Y; Department of Surgery and Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Takeishi K; Department of Surgery and Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Itoh S; Department of Surgery and Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Kobayashi N; Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
  • Ito H; Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
  • Yoshio S; Department of Liver Disease, The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba, Japan.
  • Kanto T; Department of Liver Disease, The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba, Japan.
  • Yoshizumi T; Department of Surgery and Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Fukuhara T; Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
Front Cell Infect Microbiol ; 13: 1197349, 2023.
Article en En | MEDLINE | ID: mdl-37260700

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trasplante de Hígado / COVID-19 Tipo de estudio: Risk_factors_studies Idioma: En Revista: Front Cell Infect Microbiol Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trasplante de Hígado / COVID-19 Tipo de estudio: Risk_factors_studies Idioma: En Revista: Front Cell Infect Microbiol Año: 2023 Tipo del documento: Article